Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Collegium Pharmaceutical (COLL) Other Gross PP&E Adjustments (2016 - 2025)

Collegium Pharmaceutical has reported Other Gross PP&E Adjustments over the past 10 years, most recently at $15.9 million for Q4 2025.

  • Quarterly results put Other Gross PP&E Adjustments at $15.9 million for Q4 2025, up 10.38% from a year ago — trailing twelve months through Dec 2025 was $15.9 million (up 10.38% YoY), and the annual figure for FY2025 was $15.9 million, up 10.38%.
  • Other Gross PP&E Adjustments for Q4 2025 was $15.9 million at Collegium Pharmaceutical, up from -$59.9 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for COLL hit a ceiling of $18.9 million in Q4 2023 and a floor of -$172.0 million in Q1 2025.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$52.3 million (2022), compared with a mean of -$51.6 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: surged 62.58% in 2021 and later plummeted 1285.56% in 2022.
  • Collegium Pharmaceutical's Other Gross PP&E Adjustments stood at $12.9 million in 2021, then soared by 31.78% to $17.0 million in 2022, then grew by 11.19% to $18.9 million in 2023, then decreased by 23.83% to $14.4 million in 2024, then rose by 10.38% to $15.9 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were $15.9 million (Q4 2025), -$59.9 million (Q3 2025), and -$116.2 million (Q2 2025) per Business Quant data.